/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and cloud-based software applications. Valued at $43 billion by market cap, the company offers a range of products for respiratory disorders, including diagnostic tools like ApneaLink Air and NightOwl, cloud-based platforms like AirView and myAir for patient monitoring, and U-Sleep for HME providers, connectivity solutions, as well as out-of-hospital software solutions.
Shares of this sleep tech giant have outperformed the broader market over the past year. RMD has gained 26.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 14.3%. In 2025, RMD stock is up 25%, surpassing SPX’s 9.5% rise on a YTD basis.